Market Research Report
Global Psychedelic Drugs Market (2021 Edition) - Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)
|Global Psychedelic Drugs Market (2021 Edition) - Analysis By Drug, Route of Administration, Distribution Channel, By Region, By Country: Market Insights, Pipeline Drugs and Forecast with Impact of Covid-19 (2021-2026)|
Published: May 31, 2021
Content info: 260 Pages
Delivery time: 2-3 business days
The Covid-19 pandemic has restricted the movement of people, confining them in their homes, caused severe trauma and stress in the form of sadness and loneliness and has affected the mental health of individuals. As a result, in many countries, people are facing medical conditions like depression and anxiety. The psychedelic drugs market with major potential for treatment of mental illnesses is likely to see more demand and hence likely to attract major investments in the near future.
Global Psychedelic Drugs Market was valued at USD 3.8 billion in the year 2020. The Psychedelic Drugs market is growing rapidly due to the increasing prevalence of depression and other mental disorders worldwide. The need for handling environmental stress and enhanced and better quality of lifestyle is acting as a driver for the Psychedelic Drugs market. The treatment for psychedelic drugs dependency is expected to boost psychedelic market growth.
In addition, rising research and development activities in psychedelic therapeutics categories across the world have supported industrial development significantly. Companies are aggressively investing in R&D activities to develop novel psychedelic treatment molecules with minimal side effects associated with these products. This has further resulted in a strong platform for the further growth of the psychedelic drug industry during the forecast period.
The North America region dominates the psychedelic drugs market. In North America, growing awareness of mental health disorders such as depression and stress is expected to boost the psychedelic drug market growth. Social elements such as economic stress, the partition of family-oriented supporting structures, exacerbating environmental conditions are further estimated to accelerate market growth during forecast period.
List of Tables
Table A: Current and Potential competitors with a focus on psychedelic assisted psychotherapy
Table B: Psychedelic Breakthrough Therapy Designations (BTD)
Table C: Psychedelic Compounds - Legal Status
Table D: Focused Active Ingredients & Target Markets
Table E: Prominent Psychedelic Drugs Companies operating in North America
Table F: Prominent Psychedelic Drugs Companies operating in Europe
Table G: Prominent Psychedelic Drugs companies operating in Asia Pacific
Table H: Potential Health Care Savings By Psychedelic Medicines , in USA and Europe in (USD Billion)
Table I: Select Psychedelic Clinical Trials